Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis. (Q48255358)
Jump to navigation
Jump to search
scientific article published on 12 January 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis. |
scientific article published on 12 January 2018 |
Statements
Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis (English)
Nicolas Atrux-Tallau
Franck Bihl
Aline Bondu
Claire Bouix-Peter
Isabelle Carlavan
Olivier Christin
Marie-Josée Cuadrado
Claire Defoin-Platel
Sophie Deret
Denis Duvert
Christophe Feret
Mathieu Forissier
David Froude
Fériel Hacini-Rachinel
Craig Steven Harris
Catherine Hervouet
Hélène Huguet
Guillaume Lafitte
Anne-Pascale Luzy
Branislav Musicki
Danielle Orfila
Benjamin Ozello
Coralie Pascau
Jonathan Pascau
Véronique Parnet
Guillaume Peluchon
Romain Pierre
David Piwnica
Catherine Raffin
Patricia Rossio
Delphine Spiesse
Nathalie Taquet
Etienne Thoreau
Rodolphe Vatinel
Emmanuel Vial
Laurent François Hennequin